Gavin Clark-Gartner Score: 33
Analyst at
Evercore ISI
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-11.4%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
38%
8 W / 13 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
64%
9 W / 5 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
21%
3 W / 11 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
7%
1 W / 13 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
35%
6 W / 11 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
38%
8 W / 13 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 26, 2026 |
Avalyn Pharma Inc. Common Stock
AVLN
|
BUY |
$51.00
Est. +80%
|
$28.41 | $39.99 |
Pending
|
$28.55
+0.5%
|
| May 15, 2026 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$88.00
Est. +133%
|
$37.71 | $85.03 |
Pending
|
$84.95
+125.3%
|
| May 11, 2026 |
Dianthus Therapeutics Inc
DNTH
|
BUY |
$120.00
Est. +36%
|
$88.45 | $116.45 |
Precision Hit (±3%)
|
$90.71
+2.6%
|
| Mar 04, 2026 |
Mirum Pharmaceuticals Inc
MIRM
|
BUY |
$126.00
Est. +41%
|
$89.37 | $130.00 |
Target Met
|
$89.36
0.0%
|
| Feb 18, 2026 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$34.00
Est. +69%
|
$20.14 | $36.57 |
Target Met
|
$14.77
-26.7%
|
| Feb 04, 2026 |
Abbvie Inc
ABBV
|
BUY |
$228.00
Est. +5%
|
$217.02 | $269.39 |
Target Met
|
$265.07
+22.1%
|
| Jan 28, 2026 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$45.00
Est. +36%
|
$33.14 | $34.20 |
Pending
|
$20.66
-37.7%
|
| Jan 20, 2026 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$44.00
Est. +35%
|
$32.63 | $34.20 |
Pending
|
$20.66
-36.7%
|
| Dec 15, 2025 |
Dyne Therapeutics Inc
DYN
|
BUY |
$36.00
Est. +85%
|
$19.51 | $27.31 |
Pending
|
$16.51
-15.4%
|
| Dec 08, 2025 |
Vera Therapeutics Inc - Ordinary Shares - Class A
VERA
|
BUY |
$97.00
Est. +112%
|
$45.79 | $56.05 |
Pending
|
$33.34
-27.2%
|
| Nov 06, 2025 |
Dyne Therapeutics Inc
DYN
|
BUY |
$38.00
Est. +102%
|
$18.79 | $27.31 |
Pending
|
$16.51
-12.1%
|
| Oct 01, 2025 |
Insmed Inc
INSM
|
BUY |
$180.00
Est. +23%
|
$146.31 | $212.75 |
Target Met
|
$121.55
-16.9%
|
| Jul 11, 2025 |
Avidity Biosciences Inc
RNA
|
BUY |
$70.00
Est. +123%
|
$31.45 | $73.05 |
Target Met
|
$8.19
-74.0%
|
| Sep 17, 2024 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$205.00
Est. +41%
|
$144.97 | $208.16 |
Precision Hit (±3%)
|
$230.70
+59.1%
|
| Aug 19, 2024 |
Foghorn Therapeutics Inc
FHTX
|
BUY |
$20.00
Est. +219%
|
$6.26 | $10.25 |
Miss
|
$3.60
-42.5%
|
| Aug 12, 2024 |
Krystal Biotech Inc
KRYS
|
BUY |
$206.00
Est. +13%
|
$182.17 | $207.84 |
Bullseye Hit (±1%)
|
$344.96
+89.4%
|
| Aug 08, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$179.00
Est. +31%
|
$136.40 | $144.22 |
Miss
|
$18.39
-86.5%
|
| Jul 12, 2024 |
Argen X SE - ADR
ARGX
|
BUY |
$533.00
Est. +15%
|
$461.72 | $678.21 |
Target Met
|
$962.22
+108.4%
|
| Jun 24, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$185.00
Est. +15%
|
$160.72 | $155.95 |
Miss
|
$18.39
-88.6%
|
| Jun 17, 2024 |
Mirum Pharmaceuticals Inc
MIRM
|
BUY |
$62.00
Est. +88%
|
$33.00 | $54.23 |
Miss
|
$89.36
+170.8%
|
| Apr 03, 2024 |
Jasper Therapeutics Inc
JSPR
|
BUY |
$65.00
Est. +148%
|
$26.20 | $26.05 |
Miss
|
$0.59
-97.8%
|
Avalyn Pharma Inc. Common Stock
AVLN
May 26, 2026
Signal & Target
BUY
$51.00
Start Price
$28.41
Best Price (1Y)
$39.99
Current Price
$28.55
Return
+0.5%
Crinetics Pharmaceuticals Inc
CRNX
May 15, 2026
Signal & Target
BUY
$88.00
Start Price
$37.71
Best Price (1Y)
$85.03
Current Price
$84.95
Return
+125.3%
Dianthus Therapeutics Inc
DNTH
May 11, 2026
Signal & Target
BUY
$120.00
Start Price
$88.45
Best Price (1Y)
$116.45
Current Price
$90.71
Return
+2.6%
Mirum Pharmaceuticals Inc
MIRM
Mar 04, 2026
Signal & Target
BUY
$126.00
Start Price
$89.37
Best Price (1Y)
$130.00
Current Price
$89.36
Return
0.0%
Ultragenyx Pharmaceutical Inc.
RARE
Feb 18, 2026
Signal & Target
BUY
$34.00
Start Price
$20.14
Best Price (1Y)
$36.57
Current Price
$14.77
Return
-26.7%
Abbvie Inc
ABBV
Feb 04, 2026
Signal & Target
BUY
$228.00
Start Price
$217.02
Best Price (1Y)
$269.39
Current Price
$265.07
Return
+22.1%
Viridian Therapeutics Inc
VRDN
Jan 28, 2026
Signal & Target
BUY
$45.00
Start Price
$33.14
Best Price (1Y)
$34.20
Current Price
$20.66
Return
-37.7%
Viridian Therapeutics Inc
VRDN
Jan 20, 2026
Signal & Target
BUY
$44.00
Start Price
$32.63
Best Price (1Y)
$34.20
Current Price
$20.66
Return
-36.7%
Dyne Therapeutics Inc
DYN
Dec 15, 2025
Signal & Target
BUY
$36.00
Start Price
$19.51
Best Price (1Y)
$27.31
Current Price
$16.51
Return
-15.4%
Signal & Target
BUY
$97.00
Start Price
$45.79
Best Price (1Y)
$56.05
Current Price
$33.34
Return
-27.2%
Dyne Therapeutics Inc
DYN
Nov 06, 2025
Signal & Target
BUY
$38.00
Start Price
$18.79
Best Price (1Y)
$27.31
Current Price
$16.51
Return
-12.1%
Insmed Inc
INSM
Oct 01, 2025
Signal & Target
BUY
$180.00
Start Price
$146.31
Best Price (1Y)
$212.75
Current Price
$121.55
Return
-16.9%
Avidity Biosciences Inc
RNA
Jul 11, 2025
Signal & Target
BUY
$70.00
Start Price
$31.45
Best Price (1Y)
$73.05
Current Price
$8.19
Return
-74.0%
Ascendis Pharma A/S - ADR
ASND
Sep 17, 2024
Signal & Target
BUY
$205.00
Start Price
$144.97
Best Price (1Y)
$208.16
Current Price
$230.70
Return
+59.1%
Foghorn Therapeutics Inc
FHTX
Aug 19, 2024
Signal & Target
BUY
$20.00
Start Price
$6.26
Best Price (1Y)
$10.25
Current Price
$3.60
Return
-42.5%
Krystal Biotech Inc
KRYS
Aug 12, 2024
Signal & Target
BUY
$206.00
Start Price
$182.17
Best Price (1Y)
$207.84
Current Price
$344.96
Return
+89.4%
Sarepta Therapeutics Inc
SRPT
Aug 08, 2024
Signal & Target
BUY
$179.00
Start Price
$136.40
Best Price (1Y)
$144.22
Current Price
$18.39
Return
-86.5%
Argen X SE - ADR
ARGX
Jul 12, 2024
Signal & Target
BUY
$533.00
Start Price
$461.72
Best Price (1Y)
$678.21
Current Price
$962.22
Return
+108.4%
Sarepta Therapeutics Inc
SRPT
Jun 24, 2024
Signal & Target
BUY
$185.00
Start Price
$160.72
Best Price (1Y)
$155.95
Current Price
$18.39
Return
-88.6%
Mirum Pharmaceuticals Inc
MIRM
Jun 17, 2024
Signal & Target
BUY
$62.00
Start Price
$33.00
Best Price (1Y)
$54.23
Current Price
$89.36
Return
+170.8%
Jasper Therapeutics Inc
JSPR
Apr 03, 2024
Signal & Target
BUY
$65.00
Start Price
$26.20
Best Price (1Y)
$26.05
Current Price
$0.59
Return
-97.8%